A biotechnology venture capital firm is ringing in the new year with its latest fund, having raised a quarter of $1 billion.
Cambridge, Massachusetts-based Atlas Venture said Wednesday that it closed its first Opportunity Fund, or AVOF I, with an oversubscribed fund raise of $250 million. The firm plans to invest the money in companies already in its portfolio.
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
New Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims Complements Multi-Modal Technology Platform and Extensive Intellectual Property Portfolio To Address New Brain and Behavioral Health Conditions
Tuesday, January 15, 2019 8:30AM – 10:30AM
GSK 9911 Belward Campus Drive Rockville, MD 20850
The Maryland Life Sciences, a division of the Maryland Tech Council, brings together vaccine leaders to discuss current breakthroughs in the world of vaccines and immunotherapeutics. This breakfast meeting will address innovating strategies to meet current health threats, changing technology for vaccine manufacturing and provide a snapshot of where vaccine development stands today.
Join us for breakfast, networking and a discussion to hear about the experiences and insights on the current state and projected future of treatments. Local leaders will also discuss challenges and opportunities that come with vaccine and immunotherapy development used by companies in our State.
Different places have different levels of educational achievement.
The American Community Survey is an annual survey run by the Census Bureau to allow the government, corporate and academic researchers, and anyone who is curious about demographics to better understand the US population. Among many other subjects, the ACS includes questions about respondents’ education levels.
Though federal agencies are hungry for new technology solutions, a report from the Government Accountability Office says they may be missing out on a key avenue of innovation.
Having analyzed the trends and the shifting winds in the payer marketplace, it’s time to gaze into the crystal ball and see what the future has in store.
“If you can look into the seeds of time, and say which grain will grow and which will not, speak then unto me,” Banquo beseeches the witches in Shakespeare’s “Macbeth,” seeking insight into the future for himself and his closest friend Macbeth.
Peloton tops the list of NYC fund raisers in 2018, followed by WeWork and Letgo.
Though the healthcare field is notoriously slow to adopt new technologies, IT innovation is making its way to the sector. Looking ahead, what does the future of technology in the medical world look like? One hospital executive weighed in.
New funding will support Phase 1 studies for Spiral Therapeutics’ lead drug candidate targeting inner ear disorders and hearing loss.
